
Andrew Bruce LDO, ABOM, NCLEM, FCLSA, and Mark Schaeffer, OD, FAAO, weigh in on how opticians and optometrists can work together to find ideal contact lens candidates at Vision Expo 2026 in Orlando, Florida.

Andrew Bruce LDO, ABOM, NCLEM, FCLSA, and Mark Schaeffer, OD, FAAO, weigh in on how opticians and optometrists can work together to find ideal contact lens candidates at Vision Expo 2026 in Orlando, Florida.

Glenda Aleman-Moheepith, OD, states that using technology for translation efforts can make a world of a difference in putting them at ease in your chair.

Sheila Morrison, OD, MS, explores the clinical intersection of dry eye disease and myopia control in pediatric patients—and why that intersection matters more than many practitioners realize.

Henry, MS, OD, presented a talk on how AI can help alleviate burnout for ODs during Vision Expo 2026 in Orlando, Florida.

A handful of ECPs weigh in on what ODs and MDs alike should know to spread awareness of the disease state.

John Womack, OD, details a poster on real-world data on a kalifilcon A daily disposable silicone hydrogel toric contact lens he presented at SECO 2026.

Nate Lighthizer, OD, FAAO, offers practical advice for clinicians adopting YAG capsulotomy.

Nathan Lighthizer, OD, FAAO, presented on laser trabeculoplasty for glaucoma management at this year's conference.

Mile Brujic, OD, FAAO, presented data from a study in February 2026 that examined real-world experience with lifitegrast across 12 offices—6 ophthalmology and 6 optometry practices.

Inder Paul Singh, MD, emphasized that patient compliance is a real and significant challenge in glaucoma care.

Larissa Camejo, MD, emphasized that decisions are never “black and white” and must be individualized based on the specific patient.

Cathleen McCabe, MD, details what can be done now for these patients in a sea of imperfect options.

A handful of MDs detail their presentations at this year's conference.

Rahul S. Tonk, MD, MBA, discussed his session on dry eye disease at EnVision Summit 2026, and looked ahead at the pipeline of therapies in development.

Alonso discusses his recent study highlighting pupil constriction in accommodative eye vergence as the central mechanism driving myopia progression.

Pathik Amin, OD, FAAO, gave a presentation to the optometry cohort at the conference on glaucoma management, focusing on surgical options and recent advancements.

Julia Pulliam, OD, FAAO, highlights how working in an academic medical center provides significant advantages for managing complex conditions like uveitis.

McCabe, MD, presented alongside P. Dee Stephenson, MD, FACS, for the product theater titled "Know Your Dry Eye: Navigating the Challenges of Real-World Dry Eye Cases."

Pathik P. Amin, OD, FAAO, details his segment of an educational track session on glaucoma at this year's conference.

Jason Jedlicka, OD, FAAO, talks through a presentation he gave during last week's conference.

Susan Gromacki, OD, MS, FAAO, FSLS, details her presentation given at this year's conference.

Jamie Kuzniar, OD, FAAO, FSLS, details a poster presentation that served as a follow-up to results of previous fittings of Zenlens Chroma HOA (Bausch + Lomb).

Kramer, OD, FAAO, FSLS, presented alongside Kelsea Skidmore, OD, MS; Vivien Tse, OD; and Elaine Chen, OD, at this year's conference.

Edward Choy, partner at Sho Eyeworks, shares success stories of private practices creating their own eyewear frame line.

Edward Choy, partner at Sho Eyeworks, advises practice owners on the fence of developing their own brand to dive in.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, discuss the company's price points and partner subscription options.

In this closing segment, the expert panel reflects on how clinicians can confidently introduce new dry eye therapies into practice while keeping care simple, approachable, and effective.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, drive home the importance of profitability in creating an eyewear brand.

In this segment, the expert panel turns its attention to unmet needs in dry eye disease and the future direction of therapy.

In this segment, the expert panel discusses the complexities of managing dry eye disease as a chronic, often lifelong condition.